Last10K.com

Enveric Biosciences, Inc. (ENVB) SEC Filing 8-K Material Event for the period ending Monday, June 13, 2022

Enveric Biosciences, Inc.

HISTORY TOOLS
CIK: 890821 Ticker: ENVB

View differences made from one to another to evaluate Enveric Biosciences, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Enveric Biosciences, Inc..

Continue

Assess how Enveric Biosciences, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Enveric Biosciences, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Cover
Ticker: ENVB
CIK: 890821
Form Type: 8-K Corporate News
Accession Number: 0001493152-22-016803
Submitted to the SEC: Wed Jun 15 2022 9:00:12 AM EST
Accepted by the SEC: Wed Jun 15 2022
Period: Monday, June 13, 2022
Industry: Semiconductors And Related Devices
Events:
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/envb/0001493152-22-016803.htm